Caroline Le Lan, Aurélien Belot, Camille Golfier, Bérénice Audin, Pierre Sesques, Adeline Bernier, Violaine Safar, Emmanuelle Ferrant, Anne Lazareth, Hélène Lequeu, Lionel Karlin, Dana Ghergus, Alizée Maarek, Guillaume Aussedat, Maryam Idlhaj, Gilles Salles, Fanny Cherblanc, Emmanuel Bachy, Hervé Ghesquieres
{"title":"评估教学医院血液科新诊断淋巴瘤患者一年内参与前瞻性真实世界淋巴瘤和成人生存数据(REALYSA)队列的情况和招募偏差。","authors":"Caroline Le Lan, Aurélien Belot, Camille Golfier, Bérénice Audin, Pierre Sesques, Adeline Bernier, Violaine Safar, Emmanuelle Ferrant, Anne Lazareth, Hélène Lequeu, Lionel Karlin, Dana Ghergus, Alizée Maarek, Guillaume Aussedat, Maryam Idlhaj, Gilles Salles, Fanny Cherblanc, Emmanuel Bachy, Hervé Ghesquieres","doi":"10.1002/hon.3297","DOIUrl":null,"url":null,"abstract":"","PeriodicalId":12882,"journal":{"name":"Hematological Oncology","volume":"42 4","pages":""},"PeriodicalIF":3.3000,"publicationDate":"2024-07-11","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"Evaluation of participation and recruitment bias in a prospective Real World Data in Lymphoma and Survival in Adults (REALYSA) cohort for newly diagnosed lymphoma patients over 1 year in a hematology department of teaching hospital\",\"authors\":\"Caroline Le Lan, Aurélien Belot, Camille Golfier, Bérénice Audin, Pierre Sesques, Adeline Bernier, Violaine Safar, Emmanuelle Ferrant, Anne Lazareth, Hélène Lequeu, Lionel Karlin, Dana Ghergus, Alizée Maarek, Guillaume Aussedat, Maryam Idlhaj, Gilles Salles, Fanny Cherblanc, Emmanuel Bachy, Hervé Ghesquieres\",\"doi\":\"10.1002/hon.3297\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"\",\"PeriodicalId\":12882,\"journal\":{\"name\":\"Hematological Oncology\",\"volume\":\"42 4\",\"pages\":\"\"},\"PeriodicalIF\":3.3000,\"publicationDate\":\"2024-07-11\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Hematological Oncology\",\"FirstCategoryId\":\"3\",\"ListUrlMain\":\"https://onlinelibrary.wiley.com/doi/10.1002/hon.3297\",\"RegionNum\":4,\"RegionCategory\":\"医学\",\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"Q2\",\"JCRName\":\"HEMATOLOGY\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Hematological Oncology","FirstCategoryId":"3","ListUrlMain":"https://onlinelibrary.wiley.com/doi/10.1002/hon.3297","RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q2","JCRName":"HEMATOLOGY","Score":null,"Total":0}
Evaluation of participation and recruitment bias in a prospective Real World Data in Lymphoma and Survival in Adults (REALYSA) cohort for newly diagnosed lymphoma patients over 1 year in a hematology department of teaching hospital
期刊介绍:
Hematological Oncology considers for publication articles dealing with experimental and clinical aspects of neoplastic diseases of the hemopoietic and lymphoid systems and relevant related matters. Translational studies applying basic science to clinical issues are particularly welcomed. Manuscripts dealing with the following areas are encouraged:
-Clinical practice and management of hematological neoplasia, including: acute and chronic leukemias, malignant lymphomas, myeloproliferative disorders
-Diagnostic investigations, including imaging and laboratory assays
-Epidemiology, pathology and pathobiology of hematological neoplasia of hematological diseases
-Therapeutic issues including Phase 1, 2 or 3 trials as well as allogeneic and autologous stem cell transplantation studies
-Aspects of the cell biology, molecular biology, molecular genetics and cytogenetics of normal or diseased hematopoeisis and lymphopoiesis, including stem cells and cytokines and other regulatory systems.
Concise, topical review material is welcomed, especially if it makes new concepts and ideas accessible to a wider community. Proposals for review material may be discussed with the Editor-in-Chief. Collections of case material and case reports will be considered only if they have broader scientific or clinical relevance.